SRNE logo

Sorrento Therapeutics (SRNE)

Profile

Full Name

Sorrento Therapeutics

Ticker Symbol

SRNE

Exchange

NASDAQ

Country

United States

IPO

January 19, 2007

Indexes

Not included

Employees

949

Key Details

Price

$0.00(+11.11%)

Market cap

$551.28K(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$62.84M(+18.78% YoY)

Annual EPS

-$1.37(+5.52% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Nov 2, 22 Cantor Fitzgerald
Overweight
Mar 25, 22 HC Wainwright & Co.
Buy
Aug 9, 21 HC Wainwright & Co.
Buy
Jan 21, 21 Alliance Global Partners
Buy
Jul 31, 20 HC Wainwright & Co.
Buy
May 26, 20 Dawson James
Buy
Mar 30, 20 HC Wainwright & Co.
Buy
Mar 30, 20 H.C. Wainwright
Buy
Oct 7, 19 JMP Securities
Market Outperform
Mar 20, 19 B. Riley Securities
Buy

Institutional Ownership

  • What is the ticker symbol for Sorrento Therapeutics?
  • Does Sorrento Therapeutics pay dividends?
  • What sector is Sorrento Therapeutics in?
  • What industry is Sorrento Therapeutics in?
  • What country is Sorrento Therapeutics based in?
  • When did Sorrento Therapeutics go public?
  • Is Sorrento Therapeutics in the S&P 500?
  • Is Sorrento Therapeutics in the NASDAQ 100?
  • Is Sorrento Therapeutics in the Dow Jones?
  • When was Sorrento Therapeutics's last earnings report?
  • When does Sorrento Therapeutics report earnings?
  • Should I buy Sorrento Therapeutics stock now?

What is the ticker symbol for Sorrento Therapeutics?

The ticker symbol for Sorrento Therapeutics is NASDAQ:SRNE

Does Sorrento Therapeutics pay dividends?

No, Sorrento Therapeutics does not pay dividends

What sector is Sorrento Therapeutics in?

Sorrento Therapeutics is in the Healthcare sector

What industry is Sorrento Therapeutics in?

Sorrento Therapeutics is in the Biotechnology industry

What country is Sorrento Therapeutics based in?

Sorrento Therapeutics is headquartered in United States

When did Sorrento Therapeutics go public?

Sorrento Therapeutics's initial public offering (IPO) was on January 19, 2007

Is Sorrento Therapeutics in the S&P 500?

No, Sorrento Therapeutics is not included in the S&P 500 index

Is Sorrento Therapeutics in the NASDAQ 100?

No, Sorrento Therapeutics is not included in the NASDAQ 100 index

Is Sorrento Therapeutics in the Dow Jones?

No, Sorrento Therapeutics is not included in the Dow Jones index

When was Sorrento Therapeutics's last earnings report?

Sorrento Therapeutics's most recent earnings report was on Aug 14, 2023

When does Sorrento Therapeutics report earnings?

The next expected earnings date for Sorrento Therapeutics is May 15, 2025

Should I buy Sorrento Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page